Prophecy about post-endoscopic retrograde cholangiopancreatography pancreatitis: From divination to science

被引：10

作者：

Moon, Sung-Hoon ^{[1
]}

Kim, Myung-Hwan ^{[2
]}

机构：

[1] Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Coll Med, Anyang 431070, South Korea

[2] Univ Ulsan, Dept Internal Med, Coll Med, Asan Med Ctr, Seoul 138736, South Korea

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2013年 / 19卷 / 05期

关键词：

Endoscopic retrograde cholangiopancreatography; Post-endoscopic retrograde cholangiopancreatography pancreatitis; Risk factor; Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis; Pancreatic stents; Nonsteroidal antiinflammatory drugs; RANDOMIZED CONTROLLED-TRIALS; COMMON BILE-DUCT; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NEEDLE-KNIFE FISTULOTOMY; HIGH-RISK PATIENTS; ERCP PANCREATITIS; STENT PLACEMENT; PROSPECTIVE MULTICENTER; DIFFICULT CANNULATION; BILIARY CANNULATION;

D O I：

10.3748/wjg.v19.i5.631

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

One unresolved issue of endoscopic retrograde cholangiopancreatography (ERCP) is post-ERCP pancreatitis (PEP), which occurs in up to 40% of patients. Identification of risk factors for PEP is especially important in the field of ERCP practice because it may assist physicians in taking protective measures in situations with high risk. A decade ago, Freeman et al meticulously evaluated a large number of potentially relevant risk factors for PEP, which can be divided into patient-related and procedure-related issues. In this commentary, we summarize this classic article and reevaluate the risk factors for PEP from the current point of view. This is followed by assessment of strategies for prevention of PEP that can be divided into mechanical and pharmacologic methods. (C) 2013 Baishideng. All rights reserved.

引用

页码：631 / 637

页数：7

共 63 条

[61] Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review [J].